These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27455953)

  • 1. BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.
    Hamouda MA; Jacquel A; Robert G; Puissant A; Richez V; Cassel R; Fenouille N; Roulland S; Gilleron J; Griessinger E; Dubois A; Bailly-Maitre B; Goncalves D; Mallavialle A; Colosetti P; Marchetti S; Amiot M; Gomez-Bougie P; Rochet N; Deckert M; Avet-Loiseau H; Hofman P; Karsenti JM; Jeandel PY; Blin-Wakkach C; Nadel B; Cluzeau T; Anderson KC; Fuzibet JG; Auberger P; Luciano F
    J Exp Med; 2016 Aug; 213(9):1705-22. PubMed ID: 27455953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
    Carrasco DR; Sukhdeo K; Protopopova M; Sinha R; Enos M; Carrasco DE; Zheng M; Mani M; Henderson J; Pinkus GS; Munshi N; Horner J; Ivanova EV; Protopopov A; Anderson KC; Tonon G; DePinho RA
    Cancer Cell; 2007 Apr; 11(4):349-60. PubMed ID: 17418411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
    Linden M; Kirchhof N; Kvitrud M; Van Ness B
    Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
    Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
    Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Nagoshi H; Taki T; Chinen Y; Tatekawa S; Tsukamoto T; Maegawa S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Okuno Y; Fujiwara S; Hata H; Kuroda J; Taniwaki M
    Genes Chromosomes Cancer; 2015 Dec; 54(12):788-95. PubMed ID: 26390996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.
    Cheung WC; Kim JS; Linden M; Peng L; Van Ness B; Polakiewicz RD; Janz S
    J Clin Invest; 2004 Jun; 113(12):1763-73. PubMed ID: 15199411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
    Boylan KL; Gosse MA; Staggs SE; Janz S; Grindle S; Kansas GS; Van Ness BG
    Cancer Res; 2007 May; 67(9):4069-78. PubMed ID: 17483317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of BAX in plasma cell dyscrasias.
    Renner S; Weisz J; Krajewski S; Krajewska M; Reed JC; Lichtenstein A
    Clin Cancer Res; 2000 Jun; 6(6):2371-80. PubMed ID: 10873089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
    Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
    Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER; Piché L; Lemieux G; Lemieux R
    Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
    Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
    Meister S; Schubert U; Neubert K; Herrmann K; Burger R; Gramatzki M; Hahn S; Schreiber S; Wilhelm S; Herrmann M; Jäck HM; Voll RE
    Cancer Res; 2007 Feb; 67(4):1783-92. PubMed ID: 17308121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis.
    Hueber AO; Bösser S; Zörnig M
    Int J Cancer; 2004 Nov; 112(3):536-40. PubMed ID: 15382083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental animal models of multiple myeloma].
    Miyakawa Y
    Nihon Rinsho; 2007 Dec; 65(12):2211-7. PubMed ID: 18069262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures.
    Dmoszynska A; Podhorecka M; Klimek P; Grzasko N
    Eur J Clin Pharmacol; 2006 Apr; 62(4):325-9. PubMed ID: 16523333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bcl-2 expression in plasma cells from neoplastic gammopathies and reactive plasmacytosis: a comparative study.
    Miguel-García A; Orero T; Matutes E; Carbonell F; Miguel-Sosa A; Linares M; Tarín F; Herrera M; García-Talavera J; Carbonell-Ramón F
    Haematologica; 1998 Apr; 83(4):298-304. PubMed ID: 9592978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.